ALKS vs XLF
Alkermes Plc (ALKS) versus XLF (XLF) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
XLF (XLF) common stock.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
XLF does not have a complete income-statement cache yet.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. XLF currently screens at market cap $0.
Not investment advice. Open the ALKS and XLF stock pages for the full models.
Not investment advice.